Retinoblastoma Phase II Expanded Access Clinical Trial
Clinical trial NCT06679634 · RECRUITING
Trial details
- NCT number
- NCT06679634
- Sponsor
- Targeted Therapy Technologies, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-21
- Primary completion
- 2029-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.